A transgenic mouse model for inducible and reversible dysmyelination

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Oligodendrocytes are crucial glial cells responsible for myelin sheath production in the central nervous system (CNS).
• Myelination is a critical developmental process occurring primarily postnatally.
• Understanding oligodendrocyte dynamics and the consequences of dysmyelination requires robust in vivo models.

Purpose of the Study:

• To develop an inducible model for studying oligodendrocyte ablation and dysmyelination in vivo.
• To delineate the timing of oligodendrocyte proliferation and myelination.
• To investigate the consequences of varying degrees of dysmyelination.

Main Methods:

• Generation of transgenic mice expressing herpes virus 1 thymidine kinase (HSV1-TK) under the myelin basic protein (MBP) promoter (MBP-TK mice).
• Induction of oligodendrocyte toxicity and ablation via systemic injection of the nucleoside analog FIAU.
• Observation of behavioral phenotypes and histological analysis following FIAU treatment.

Main Results:

• Chronic FIAU treatment during the first three postnatal weeks led to near-complete oligodendrocyte depletion and significant CNS dysmyelination.
• Treated mice exhibited tremors, seizures, growth retardation, and premature death, indicating severe neurological impairment.
• The period of highest oligodendrocyte division was identified as the first 9 postnatal days; delayed FIAU treatment resulted in variable dysmyelination.
• Astrocytosis consistently accompanied dysmyelination in the MBP-TK mouse model.

Conclusions:

• The developed MBP-TK transgenic model provides a powerful tool for controlled, inducible oligodendrocyte ablation and the study of dysmyelination.
• This model enables investigation into the varying intensities of dysmyelination and associated pathological changes like astrocytosis.
• It serves as an invaluable resource for exploring potential therapeutic strategies, including remyelination, in vivo.